Valeant Pharma (VRX) says ex-CEO Pearson is still consulting in 'limited' capacity - Conf. call

November 8, 2016 8:57 AM EST

Get daily under-the-radar research with's Stealth Growth Insider Get your 2-Wk Free Trial here.

Valeant Pharma (NYSE: VRX) says ex-CEO Mike Pearson is still consulting in 'limited' capacity, according to the company's conference call on Tuesday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Insiders' Blog

Add Your Comment